『2 Minutes with Joey - REGN Stock News』のカバーアート

2 Minutes with Joey - REGN Stock News

2 Minutes with Joey - REGN Stock News

著者： 2 Minutes with Joey
無料で聴く

Two minutes with Joey on Regeneron Pharmaceuticals (REGN) - a quick daily recap of what the stock did today and why, in plain English. Information and entertainment only, not financial advice.Copyright 2 Minutes with Joey 社会科学
エピソード
  • REGN Today - Aug 12: Stock Slightly Down

    REGN Today - Aug 12: Stock Slightly Down
    2026/08/12
    Hey there! It’s Joey here, your friendly longtime investor, and today we're talking about Regeneron Pharmaceuticals, or REGN for short. It was a red day for them, down just a tiny bit—like, 0.31%.

    So, what went down? The stock barely moved, but it did get a little smoked compared to some of its competitors. You know how it is—some days you’re just not in the spotlight, and today was one of those days for Regeneron. There was a bit of chatter about their valuation after some recent earnings reports, but honestly, nothing too wild happened to shake things up.

    Now, why the dip? Well, a few articles pointed out that Regeneron’s performance wasn’t exactly stellar compared to other stocks in the same space. People were looking at their competitors and thinking, “Wow, they’re doing better.” Plus, there was some buzz about investment firms adjusting their positions. Like, Handelsbanken trimmed their stake, and that kind of stuff can make folks a little jittery. It’s like when your friend suddenly decides they don’t want to hang out anymore—kinda makes you question things, right?

    On the horizon, it’s worth knowing that Regeneron has been on a roll recently, soaring about 21.9% in the month leading up to today. So, while today was a bit of a slow bleed, they’ve had their moments.

    Alright, that’s the scoop for today! Just remember, this is all for your info and entertainment, not financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • REGN Today - Aug 11: Slight Dip Amid Mixed News

    REGN Today - Aug 11: Slight Dip Amid Mixed News
    2026/08/11
    Hey there! It’s Joey here, your friendly investor buddy. Let’s chat about Regeneron Pharmaceuticals, ticker REGN. Today was a bit of a red day, with the stock dipping just a smidge, down about a quarter percent.

    So, what went down? Well, today’s trading was pretty chill overall. REGN barely moved, just a slight drop, but it seems like the stock was holding its own against some of its competition. There was some strong trading action in the biotech space, but our buddy Regeneron just kinda floated along.

    Now, let’s get into the why behind this move. NewEdge Advisors just announced they’re holding about $5.88 million in REGN. That’s some solid backing, right? Plus, Contravisory Investment Management scooped up over 10,000 shares. Always nice to see folks betting on the stock. On the flip side, there was news about a class action deadline coming up that might’ve put a little weight on the stock. It’s like when you’re cruising along, and then a random speed bump shows up outta nowhere – yeah, that one stung a bit.

    And here’s something to keep in mind: analysts are still giving REGN a “moderate buy” rating, which is kinda reassuring. It means people still believe in the potential here, even if today felt a little sleepy.

    So, to wrap it up, REGN had a quiet day, dipped just a tad, but there’s still some interest from investors, and analysts are mostly positive. Just remember, this is all for fun and info, not financial advice. Catch you later, and happy investing!
    続きを読む 一部表示
    1 分
  • REGN Today - Aug 10: Mixed News on Buybacks and Dividends

    REGN Today - Aug 10: Mixed News on Buybacks and Dividends
    2026/08/10
    Hey there! It’s Joey here, your friendly neighborhood investor, and today we’re chatting about Regeneron Pharmaceuticals, also known as REGN. So, how’d it do today? It was a green day, up about 1.5%. Not too shabby!

    Now, let’s break down what went down. The stock had a pretty solid day, bouncing up a bit, but it wasn’t all sunshine and rainbows. There was some action with shares changing hands—some folks buying and selling like it was a game of hot potato. Contravisory Investment Management picked up over 10,000 shares, which is a good sign. But then, on the flip side, Beacon Investment Advisory sold off about 9,000 shares. So, it’s like a mixed bag of vibes today.

    But why the movement? Well, it seems like there’s a lot of chatter about Regeneron’s buyback strategy and dividends. They’re keeping those in focus, and investors are paying attention. When a company talks about returning value to shareholders, it can make people feel a little more secure. Plus, there’s some buzz around their drug Dupilumab, which is showing promise for treating allergic fungal rhinosinusitis. That’s definitely a win for the company and could be driving some interest.

    One thing to keep an eye on? Regeneron’s fair value seems to be in sight, which could mean there’s more room for growth. It’s always good to know where a company stands in the market.

    So, to wrap this up, Regeneron had a decent day, with mixed news on buying and selling shares. They’re focused on buybacks and dividends, and their drug developments are looking promising. Just remember, this is all for your info and fun, not financial advice. Catch you later!
    続きを読む 一部表示
    2 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません